Digital Content 
NEWS #PharmaBuzz
21 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/21/2933532/0/en/Scilex-Holding-Company-Announces-the-U-S-Patent-and-Trademark-Office-Will-Be-Issuing-New-ELYXYB-Patent-Related-to-the-Treatment-of-Acute-Pain.html
08 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/08/2927020/0/en/Virios-Therapeutics-Announces-Second-Quarter-2024-Financial-Results.html
13 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/13/2898313/0/en/Scilex-Holding-Company-to-Present-Poster-on-ELYXYB-celecoxib-oral-solution-at-the-66th-Annual-Scientific-Meeting-of-the-American-Headache-Society-AHS-to-be-Held-in-San-Diego-CA-on-.html
06 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/06/2895001/0/en/Scilex-Holding-Company-announces-the-U-S-FDA-has-approved-the-sNDA-for-commercial-manufacturing-of-Gloperba-which-will-be-launched-in-the-US-in-the-week-of-June-10th-2024.html
18 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/18/2847865/0/en/Scilex-Holding-Company-Provides-Responses-to-Product-Composition-Questions-Related-to-its-ELYXYB-Patent-in-Canada-for-a-New-Drug-Submission-Under-Review-by-Health-Canada-for-the-Ap.html
https://www.globenewswire.com//news-release/2024/01/18/2811519/37414/en/Panbela-Announces-Publication-of-Clinical-Data-Titled-Phase-1-study-of-high-dose-DFMO-celecoxib-cyclophosphamide-and-topotecan-for-patients-with-relapsed-neuroblastoma-A-New-Approa.html
Share 